Related Experiment Video
Updated: Dec 24, 2025

Atomic Force Microscopy Combined with Infrared Spectroscopy as a Tool to Probe Single Bacterium Chemistry
Published on: September 15, 2020
Study on the virulome and resistome of a vancomycin intermediate-resistance Staphylococcus aureus
Jie Fu1, Kan Wang2, Congxiu Ye3
1Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China.
Abstract:
Methicillin-resistant S. aureus (MRSA) has been considered a potential "Super Bugs", responsible for various infectious diseases. Vancomycin has been the most effective antibitic to treat MRSA originated infections. In this study, we aimed at investigating the genomic features of a vancomycin intermediate-resistance S. aureus strain Guangzhou-SauVS2 isolated from a female patient suffering from chronic renal function failure, emphasizing on its antimicrobial resistance and virulence determinants. The genome has a total length of 2,605,384 bp and the G+C content of 33.21%, with 2,239 predicted genes annotated with GO terms, COG categories, and KEGG pathways. Besides the carriage of vancomycin b-type resistance protein responsible for the vancomycin intermediate-resistance, S. aureus strain Guangzhou-SauVS2 showed resistance to β-lactams, quinolones, macrolide, and tetracycline, due to the acquisition of corresponding antimicrobial resistance genes. In addition, virulence factors including adherence, antiphagocytosis, iron uptake, and toxin were determined, indicating the pathogenesis of the strain.
Insights
This study details the genomic features of a vancomycin-intermediate resistant Staphylococcus aureus (MRSA) strain, Guangzhou-SauVS2. It highlights the strain
Area of Science:
- Microbiology
- Genomics
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant public health concern, often termed a "Super Bug".
- Vancomycin is a critical antibiotic for treating MRSA infections.
- Intermediate resistance to vancomycin in MRSA poses a growing therapeutic challenge.
Purpose of the Study:
- To investigate the genomic characteristics of a vancomycin-intermediate resistant MRSA strain, Guangzhou-SauVS2.
- To identify antimicrobial resistance and virulence determinants in this specific MRSA strain.
- To understand the genetic basis of MRSA pathogenesis in a clinical context.
Main Methods:
- Whole-genome sequencing of the S. aureus strain Guangzhou-SauVS2.
- Bioinformatic analysis including gene annotation (GO, COG, KEGG).
- Identification and characterization of antimicrobial resistance genes and virulence factors.
Main Results:
- The Guangzhou-SauVS2 genome is 2,605,384 bp with 33.21% G+C content and 2,239 predicted genes.
- The strain possesses a vancomycin B-type resistance protein conferring intermediate resistance.
- Acquired resistance genes for beta-lactams, quinolones, macrolides, and tetracyclines were identified, alongside virulence factors (adherence, antiphagocytosis, iron uptake, toxins).
Conclusions:
- The genomic analysis of MRSA strain Guangzhou-SauVS2 reveals a complex resistance profile beyond vancomycin.
- The identified virulence factors contribute to the strain's pathogenic potential.
- Understanding these genomic features is crucial for developing effective treatment strategies against multidrug-resistant MRSA.
Related Concept Videos
Development of Antibiotic Resistance
Antimicrobial Effectiveness

